Home/Filings/4/0001209191-18-062120
4//SEC Filing

Kroeger Christopher A. 4

Accession 0001209191-18-062120

CIK 0001544227other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:43 PM ET

Size

5.8 KB

Accession

0001209191-18-062120

Insider Transaction Report

Form 4
Period: 2018-12-07
Kroeger Christopher A.
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-05-10+47,66647,666 total
    Exercise: $13.98Exp: 2028-05-10Common Stock (47,666 underlying)
Footnotes (2)
  • [F1]Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.
  • [F2]The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).

Issuer

Millendo Therapeutics, Inc.

CIK 0001544227

Entity typeother

Related Parties

1
  • filerCIK 0001658918

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:43 PM ET
Size
5.8 KB